Your browser doesn't support javascript.
loading
Exogenous oxygen is required for prostanoid induction under brain ischemia as evidence for a novel regulatory mechanism.
Seeger, Drew R; Schofield, Brennon; Besch, Derek; Golovko, Svetlana A; Kotha, Peddanna; Parmer, Meredith; Solaymani-Mohammadi, Shahram; Golovko, Mikhail Y.
Afiliación
  • Seeger DR; Department of Biomedical Sciences, School of Medicine and Health Science, University of North Dakota, Grand Forks, ND, USA.
  • Schofield B; Department of Biomedical Sciences, School of Medicine and Health Science, University of North Dakota, Grand Forks, ND, USA.
  • Besch D; Department of Biomedical Sciences, School of Medicine and Health Science, University of North Dakota, Grand Forks, ND, USA.
  • Golovko SA; Department of Biomedical Sciences, School of Medicine and Health Science, University of North Dakota, Grand Forks, ND, USA.
  • Kotha P; Department of Biomedical Sciences, School of Medicine and Health Science, University of North Dakota, Grand Forks, ND, USA.
  • Parmer M; Department of Biomedical Sciences, School of Medicine and Health Science, University of North Dakota, Grand Forks, ND, USA.
  • Solaymani-Mohammadi S; Department of Biomedical Sciences, School of Medicine and Health Science, University of North Dakota, Grand Forks, ND, USA.
  • Golovko MY; Department of Biomedical Sciences, School of Medicine and Health Science, University of North Dakota, Grand Forks, ND, USA. Electronic address: mikhail.golovko@und.edu.
J Lipid Res ; 64(11): 100452, 2023 11.
Article en En | MEDLINE | ID: mdl-37783389
ABSTRACT
Previously, we and others reported a rapid and dramatic increase in brain prostanoids (PG), including prostaglandins, prostacyclins, and thromboxanes, under ischemia that is traditionally explained through the activation of esterified arachidonic acid (204n6) release by phospholipases as a substrate for cyclooxygenases (COX). However, the availability of another required COX substrate, oxygen, has not been considered in this mechanism. To address this mechanism for PG upregulation through oxygen availability, we analyzed mouse brain PG, free 204n6, and oxygen levels at different time points after ischemic onset using head-focused microwave irradiation (MW) to inactivate enzymes in situ before craniotomy. The oxygen half-life in the ischemic brain was 5.32 ± 0.45 s and dropped to undetectable levels within 12 s of ischemia onset, while there were no significant free 204n6 or PG changes at 30 s of ischemia. Furthermore, there was no significant PG increase at 2 and 10 min after ischemia onset compared to basal levels, while free 204n6 was increased ∼50 and ∼100 fold, respectively. However, PG increased ∼30-fold when ischemia was followed by craniotomy of nonMW tissue that provided oxygen for active enzymes. Moreover, craniotomy performed under anoxic conditions without MW did not result in PG induction, while exposure of these brains to atmospheric oxygen significantly induced PG. Our results indicate, for the first time, that oxygen availability is another important regulatory factor for PG production under ischemia. Further studies are required to investigate the physiological role of COX/PG regulation through tissue oxygen concentration.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Isquemia Encefálica / Prostaglandinas Límite: Animals Idioma: En Revista: J Lipid Res Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Isquemia Encefálica / Prostaglandinas Límite: Animals Idioma: En Revista: J Lipid Res Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos